PRESS RELEASE
8 October 2025

Sheppard Mullin Attorneys Named "Life Science Stars” In LMG Life Sciences 2025

SM
Sheppard Mullin Richter & Hampton

Contributor

Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
LMG Life Sciences recently released the 2025 edition of its guide, which identifies and ranks the leading law firms and individuals in the life sciences industry across the United States.
United States

LMG Life Sciences recently released the 2025 edition of its guide, which identifies and ranks the leading law firms and individuals in the life sciences industry across the United States. The rankings are the result of firm participation in questionnaires, partner interviews to gather market feedback, client surveys and independent research. This year, eight Sheppard Mullin attorneys have been recognized in the guide, including:

  • Martin Bruehs, Intellectual Property: Patent Prosecution
  • Dominick DiSabatino, FDA: Pharmaceutical (Rising Star)
  • Jeffrey Fessler, Corporate
  • Alexandra Kitson, FDA: Pharmaceutical (Rising Star)
  • Scott Liebman, FDA: Pharmaceutical and FDA: Medical Device
  • Alex Nie, Intellectual Property: Patent Prosecution
  • Lorna Tanner, Intellectual Property: Patent Strategy & Management
  • Daniel Yannuzzi, Intellectual Property: Patent Prosecution; Patent Strategy & Management; and General Patent Litigation

Contributor

Sheppard Mullin is a full service Global 100 firm with over 1,000 attorneys in 16 offices located in the United States, Europe and Asia. Since 1927, companies have turned to Sheppard Mullin to handle corporate and technology matters, high stakes litigation and complex financial transactions. In the US, the firm’s clients include more than half of the Fortune 100.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More